春立医疗跌1.82%

Core Viewpoint - The company, Spring Medical, is a leading domestic orthopedic medical device manufacturer specializing in the research, production, and sales of implantable orthopedic medical devices, with a focus on joint prosthetics and spinal implants. Group 1: Company Overview - Spring Medical is primarily engaged in the development, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants, covering major human joints such as hip, knee, shoulder, and elbow [2][5]. - The company has received registration certificates for surgical robots for hip and knee joint surgeries, as well as medical image processing software for surgical planning, indicating its investment in smart medical technology [2][3]. - The company is recognized as a "specialized and innovative" small giant enterprise, which signifies its strong innovation capabilities and high market share in niche markets [3]. Group 2: Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a year-on-year increase of 213.21% [8]. - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [9]. Group 3: Market Position and Shareholder Information - As of September 30, 2025, the number of shareholders in Spring Medical was 6,164, an increase of 4.12% compared to the previous period, with an average of 46,906 circulating shares per person, a decrease of 3.95% [8]. - The top circulating shareholders include Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed Fund A, both of which are new shareholders [9].